巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Vericel Corp

    VCEL
    30.960
    1.080
    3.61%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Vericel Corp - 延遲價格・最後更新於 18/08 8:28
    最高位
    31.210
    最低位
    29.220
    開市價
    --
    前收市價
    29.880
    成交量(千)
    12.87
    成交額(百萬)
    3.40
    買入
    24.690
    賣出
    37.410
    每手股數
    --
    市值(百萬)
    1,460.63
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    60.240 - 22.420
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Vericel Corp
    證券代碼
    VCEL.US
    所屬板塊
    Biotechnology
    公司業務
    Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.
    發行量
    47119902
    公司總部
    64 Sidney Street
    公司網址
    https://www.vcel.com
    公司電郵
    ir@vcel.com
    公司電話
    +1 617 588-5555
    暫無內容

    關於

    Vericel Corp(VCEL.US)所屬的行業板塊為Biotechnology。
    Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.
    詳細公司背景可參考: https://www.vcel.com